Ayurvedic products now becomes the first choice in pharma & cosmetic use

  • News
  • September 4, 2017

Dr. DBA Narayana, chief scientific officer, Ayurvidye Trust said that the demand for Ayurvedic medicines will now see demanding for their use through food, drug, and partly cosmetic route. He also said that there were no clear regulations for using them through food route. Available routes were classical Ayurveda medicine or as a proprietary Ayurvedic medicine or adding them as ingredients in cosmetics for external applications.

The things will be changes as government notified about nutraceuticals regulation. Traditional herbal industry not spending funds in research or development or even generating specific data and sold products with just reference of Vaidyas.  The growth of pure classical grantha preparations has been rather slow and the market suffers from authentic data.

There is also a lack of the investment for herbal growth or research work from the government sector.  Only Central Scientific Industry Research (CSIR) labs, National Medicinal Plants Board, ICMR went on to support scientific work on herbs.

If we consider products in terms of safety and efficacy, then only 400 ingredients known in Ayurveda industry.  For food ingredients, only permitted levels of these products can be used and above that particular levels, it can consider it under a medicinal category. With new regulations, the industry needs to use Ayurveda as per the regulation to seek drug licenses.

With the new regulation, the best thing that happened is permission to use botanicals to be used in its raw herb form to be processed into ingredients like extracts and distilled oils which are oleoresins.

Now with new innovations and demand, the growth of Ayurvedic products will be going to high and farmers will start to cultivating medicinal herbs under the supervision of companies that will source it.

 

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 267 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July